#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2850	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1962	267.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1406	1406	C	327	C	202	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2850	16S	1529	1529	100.0	16S.l15.c4.ctg.1	1962	267.5	0	HET	.	.	.	C207T	.	207	207	C	429	429	C	245	C,T	134,24	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4970	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3571	245.7	0	.	n	.	0	T695C	SNP	695	695	T	1111	1111	C	354	C	213	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4970	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3571	245.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	2054	2054	G	225	G,A	108,39	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4970	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3571	245.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2387	2387	C	190	C	112	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4970	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3571	245.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2461	2461	A	179	A	110	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	4970	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3571	245.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3013	3013	C	310	C,T	190,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	164	folP	855	855	100.0	folP.l15.c4.ctg.1	1268	23.5	1	SNP	p	R229S	1	.	.	685	687	AGC	906	908	AGC	13;13;13	A;G;C	8;8;8	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	1	566	gyrA	2751	2255	99.82	gyrA.l15.c4.ctg.1	2562	30.6	1	SNP	p	S91F	1	.	.	271	273	TTC	578	580	TTC	42;42;42	T;T;C	29;28;27	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	1	566	gyrA	2751	2255	99.82	gyrA.l15.c4.ctg.1	2562	30.6	1	SNP	p	G95N	0	.	.	283	285	GGC	590	592	GGC	43;43;43	G;G;C	30;29;27	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	1	566	gyrA	2751	2255	99.82	gyrA.l15.c4.ctg.1	2562	30.6	1	SNP	p	D95G	1	.	.	283	285	GGC	590	592	GGC	43;43;43	G;G;C	30;29;27	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	1	566	gyrA	2751	443	100.0	gyrA.l15.c4.ctg.2	669	37.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	126	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1528	16.6	1	SNP	p	G45D	0	.	.	133	135	GGC	489	491	GGC	37;37;37	G;G;C	23;23;23	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	120	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	636	27.9	0	.	n	.	0	A197.	DEL	197	197	A	303	303	A	38	A	25	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	402	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2812	25.1	1	SNP	p	D86N	0	.	.	256	258	GAC	504	506	GAC	32;32;32	G;A;C	18;14;18	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	402	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2812	25.1	1	SNP	p	R87W	0	.	.	259	261	CGT	507	509	CGT	34;34;33	C;G;T	20;17;17	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	402	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2812	25.1	1	SNP	p	R87I	0	.	.	259	261	CGT	507	509	CGT	34;34;33	C;G;T	20;17;17	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	402	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2812	25.1	1	SNP	p	S87R	1	.	.	259	261	CGT	507	509	CGT	34;34;33	C;G;T	20;17;17	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	402	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2812	25.1	1	SNP	p	S88P	0	.	.	262	264	TCC	510	512	TCC	35;35;34	T;C;C	20;19;18	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	352	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2390	26.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1430	1432	GGC	9;9;9	G;G;C	7;6;6	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	470	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2582	33.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1446	1448	GCC	52;52;52	G;C;C	33;34;34	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	470	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2582	33.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1449	1451	ATG	52;51;51	A;T;G	34;32;33	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	470	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2582	33.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1461	1463	ACC	52;52;52	A;C;C	34;34;34	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	470	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2582	33.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1461	1463	ACC	52;52;52	A;C;C	34;34;34	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	470	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2582	33.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1962	1964	ACC	46;45;46	A;C;C	29;29;29	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	470	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2582	33.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2016	2018	GCG	38;38;38	G;C;G	23;24;24	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	470	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2582	33.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2016	2018	GCG	38;38;38	G;C;G	23;24;24	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	470	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2582	33.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2139	2141	GGT	37;37;37	G;G;T	25;23;23	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	470	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2582	33.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2148	2150	AGC	24;24;23	A;G;C	16;17;16	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	470	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2582	33.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2166	2168	CCG	13;13;13	C;C;G	9;9;7	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1018	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3189	52.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1654	1656	CCG	24;24;24	C;C;G	12;15;15	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	264	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1917	24.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	452	452	C	15	C	9	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	32	porB1a	984	297	91.03	porB1a.l6.c30.ctg.1	526	5.9	0	.	p	.	0	H217N	NONSYN	649	651	CAT	252	254	AAT	8;8;8	A;A;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	32	porB1a	984	297	91.03	porB1a.l6.c30.ctg.1	526	5.9	0	.	p	.	0	D218N	NONSYN	652	654	GAT	255	257	AAT	8;8;8	A;A;T	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	32	porB1a	984	297	91.03	porB1a.l6.c30.ctg.1	526	5.9	0	.	p	.	0	V226A	NONSYN	676	678	GTA	279	281	GCA	6;6;6	G;C;A	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	32	porB1a	984	297	91.03	porB1a.l6.c30.ctg.1	526	5.9	0	.	p	.	0	.	MULTIPLE	700	702	ACT	302	304	GTA	6;6;6	G;T;A	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	32	porB1a	984	297	91.03	porB1a.l6.c30.ctg.1	526	5.9	0	.	p	.	0	N237fs	FSHIFT	709	709	A	311	311	A	6	A	3	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	330	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1471	40.9	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	333	335	CAG	29;29;29	C;A;G	23;22;22	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	330	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1471	40.9	1	SNP	p	G120K	1	.	.	358	360	AAG	573	575	AAG	36;36;37	A;A;G	22;27;23	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	330	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1471	40.9	1	SNP	p	A121N	1	.	.	361	363	AAC	576	578	AAC	37;34;34	A;A;C	27;24;21	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	330	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1471	40.9	1	SNP	p	N121D	0	.	.	361	363	AAC	576	578	AAC	37;34;34	A;A;C	27;24;21	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1232	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5001	45.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	118	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1094	20.5	1	SNP	p	V57M	1	.	.	169	171	ATG	498	500	ATG	43;39;39	A;T;G	26;25;24	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
